Cutaneous wound repair

Wounds

Volumn 10, Issue 1, 1998, Pages 12-32

  Calvin, Melissa ^a  

^a GUY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0032331067     PISSN: 10447946     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (252)

1. Lazarus GS, Cooper DM, Knighton DR, et al. Definitions and guidelines for assessment of wounds and evaluation of healing. Arch Dermatol 1994;130:489-493.
2. Goepel JR. Responses to cellular injury. In: Underwood JCE (ed). General and Systemic Pathology, Second Edition. London, UK, Churchill Livingstone, 1996, pp 121-122.
3. Forrester JC. Mechanical, biochemical and architectural features of surgical repair. Adv Biol Med Phys 1973;14:1-3.
4. Walter JB, Talbot IC. Wound healing. In: Walter and Israel (eds). General Pathology, Seventh Edition. London, UK, Churchill Livingstone, 1996, pp 165-180.
5. Clark RAF. Wound repair; overview and general considerations. In: Clark RAF (ed). The Molecular and Cellular Biology of Wound Repair, Second Edition. London, UK, Plenum Press, 1996, pp3-50.
6. Gailit J, Clark RAF. Wound repair in the context of extracellular matrix. Current Opinion in Cell Biology 1994;6:717-725.
7. Thomas DW, O'Neill ID, Harding KG, et al. Cutaneous wound healing: a current perspective. J Oral Maxillofac Surg 1995;53:442-447.
8. Yamada KM, Clark RAF. Provisional matrix. In: Clark RAF (ed). The Molecular and Cellular Biology of Wound Repair, Second Edition. London, UK, Plenum Press, 1996, pp 51-94.
9. Lanir N, Ciano PS, van de Water L, et al. Macrophage migration in fibrin gel matrices II. Effects of clotting factor XIII, fibronectin and glycosaminoglycan content on cell migration. J Immunol 1988;140:2340-2349.
10. Koopmann CF Jr. Cutaneous wound healing; an overview. Otolaryngologic Clinics of North America 1995;28(5):835-845.
11. Kaplan AP. Hageman factor-dependent pathways: mechanism of initiation and bradykinin formation. Fed Proc 1983;42:3123-3127.
12. Marlar K, Kleiss A, Griffin JH. An alternative extrinsic pathway of human blood coagulation. Blood 1982;60:1353-1356.
13. Rudolph R, Shannon ML. The normal healing process. In: Eaglstein WH (ed). Wound Care Manual: New Directions in Wound Healing. Princeton, NJ, Convatec, 1990, pp 9-24.
14. Ginsberg M. Role of platelets in inflammation and rheumatic disease. Adv Inflam Res 1981;2:53-55.
15. Katz MH, Kirsner RS, Eaglstein WH, et al. Human wound fluid from acute wounds stimulates fibroblast and endothelial cell growth. J Am Acad Dermatol 1991;25:1054-1058.
16. Heldin C, Westermark B. Role of platelet-derived growth factor in vivo. In: Clark RAF (ed). The Molecular and Cellular Biology of Wound Repair, Second Edition. London, UK, Plenum Press, 1996, pp 249-274.
17. Deuel TF, Senior RM, Chang D, et al. Platelet factor 4 is a chemotactic factor for neutrophils and monocytes. Proc Natl Acad Sci USA 1981;74:4584-1587.
18. Schultz G, Rotari DS, Clark W. EGF and TGFa in wound healing and repair. J Cell Biochem 1991;45:346-352.
19. Sporn MB, Roberts AM. Transforming growth factor beta: recent progress and new challenges. J Cell Biol 1992;119:1017-1021.
20. Moncada S, Gryglewski R, Bunting S, et al. An enzyme isolated from arteries transforms prostaglandin endoperoxidases to an unstable substance that inhibits platelet aggregation. Nature 1976;263:663-665.
21. Stern DM, Nawroth PP, Marcum J, et al. Interaction of antithrombin III with bovine aortic segments. J Clin Invest 1985;75:272-279.
22. Loedam JA, Meijers JCM, Sixma JJ, et al. Inactivation of human factor VII by activated protein C: cofactor activity of protein S and protective effect of von Willebrand factor. J Clin Invest 1988;82:1236-1243.
23. Romer J, Bugge TH, Pyke C, et al. Impaired wound healing in mice with a disrupted plasminogen gene. Nature Medicine 1996;2(3):287-292.
24. Proud D, Kaplan AP. Kinin formation: mechanisms and role in inflammatory disorders. Ann Rev Immunol 1988;6:49-83.
25. Ghebrehiwet B, Silverberg M, Kaplan AP. Activation of classic pathway of complement, by hageman factor fragment. J Exp Med 1981;153:665-676.
26. Craddock P, Fehr J, Dalmasso A, et al. Haemodialysis leukopenia: pulmonary vascular leukostasis resulting from complement activation by dialyzer cellophane membrane. J Clin Invest 1977;59:879-888.
27. Williams TJ, Jose PL. Medication of increased vascular permeability after complement activation: histamine independent activation of C5a. J Exp Med 1981;153:136-153.
28. Terragno NA, Lonigro AJ, Malik KW, et al. The relationship of the renal vasodilator action of bradykinin to the release of PGE-like substances. Experimentia 1972;28:437-439.
29. Williams TJ. Factors that affect vessel reactivity and leukocyte emigration. In: Clark RAF, Henson PM (eds). The Molecular and Cellular Biology of Wound Repair. London, UK, Plenum Press, 1988, pp 115-183.
30. Wedmore CV, Williams TJ. Control of vascular permeability by polymorphonuclear leukocytes, in inflammation. Nature 1981;289:646-650.
31. Marder SR, Chenoweth DE, Goldstein IM, et al. Chemotactic responses of human peripheral blood monocytes to the complement-derived peptides C5a and C5a des Arg. J Immunol 1985;134:3325-3331.
32. Turk JL, Heather CJ, Diengdoh JV. A histochemical analysis of mononuclear cell infiltrates of the skin, with particular reference to delayed hypersensitivity in the guinea pig. Int Arch Allergy Appl Immunol 1976;29:278-289.
33. Senior RM, Skogen WF, Griffin GI. Effects of fibrinogen derivatives upon the inflammatory response. J Clin Invest 1986;77:1014-1019.
34. McKenzie R, Pepper DS, Kay AB. The generation of chemotactic activity for human leukocytes by the action of plasmin on human fibrinogen. Thromb Res 1975;6:1-8.
35. Ford-Hutchinson AW, Bray MA, Doig MV, et al. Leukotriene B, a potent chemokinetic and aggregating substance, released from polymorphonuclear leukocytes. Nature 1980;286:264-265.
36. Freer RJ, Day AR, Radding JA, et al. Further studies on the structural requirement for synthetic peptide chemoattractants. Biochem 1980;19:2404-2410.
37. Hanahan DJ. Platelet activating factor: a biologically active phosphoglyceride. Ann Rev Biochem 1986;55:483-509.
38. Ming WJ, Bersani L, Mantovani A. Tumour necrosis factor is chemotactic for monocytes and polymorphonuclear leukocytes. J Immunol 1987;138:469-474.
39. Pierce GF, Mustoe TA, Lingelbach J, et al. Platelet derived growth factor and transforming growth factor-beta enhance tissue repair activities by unique mechanisms. J Cell Biol 1989;109:429-440.
40. Riches DWH. Macrophage involvement in wound repair, remodelling and fibrosis. In: Clark RAF (ed). The Molecular and Cellualr Biology of Wound Repair, Second Edition. London, UK, Plenum Press, 1996, pp 95-141.
41. Baggiolini M, Dewald B, Moser B. Interleukin-8 and related chemotactic cytokines-CXC and CC chemokines. Adv Immunol 1994;55:97-179.
42. Kunkel SL, Standiford T, Kasahara K, et al. Stimulus specific induction of monocyte chemotactic protein-1 (MCP-1) gene expression. Adv Exp Med Biol 1991;305:65-71.
43. Sherry B, Tekamp O, Gallegos C, et al. Resolution of the two components of macrophage inflammatory protein 1, and cloming and characterisation of one of those components, macrophage inflammatory protein 1 beta. J Exp Med 1988;168:2251-2259.
44. Pierce GF, Yanagihara D, Costigan V, et al. Platelet-derived endothelial cell growth factor (PD-ECGF) in angiogenesis and wound healing. Cited from abstract, 1st European Issue Repair Society Meeting, Oxford, UK, 1991.
45. Bar-Shavit R, Kahn A, Fenton JW, et al. Chemotactic response of monocytes to thrombin. J Cell Biol 1983;96:282-285.
46. Postlethwaite AE, Kang AH. Collagen and collagen peptide-induced chemotaxis of human blood monocytes. J Exp Med 1976;143:1299-1307.
47. Senior RM, Griffin GL, Mecham RP. Chemotactic activity of elastin-derived peptides. J Clin Invest 1980;66:859-862.
48. Senior RM, Griffin GL, Mecham RP, et al. Val-Gly-Val-Ala-Pro-Gly, a repeating peptide in elastin, is chemotactic for fibroblasts and monocytes. J Cell Biol 1984;99:870-874.
49. Clark RAF. Cutaneous wound repair. In: Goldsmith LE (ed). Biochemistry and Physiology of the Skin. Oxford, UK, Oxford University Press, 1990, pp 575-601.
50. Cochrane CG, Gimbrone MA Jr. Leukocyte-endothelial adhesion molecules. Cellular and Molecular Mechanisms of Inflammation; Volume 3. San Diego, CA, Academic Press, 1992.
51. Springer TA. Adhesion receptors of the immune system. Nature 1990;346:425-434.
52. Anderson DC, Springer TA. Leucocyte adhesion deficiency: an inherited defect in the Mac-1, LFA-1 and gp150,95 glycoproteins. Annu Rev Med 1987;38:175-194.
53. Amaout MA. Leucocyte adhesion molecule deficiency: its structural basis, pathophysiology and implications for modulating the inflammatory response. Immunol Rev 1990;114:145-180.
54. Zimmerman GA, Prescott SM, McIntyre TM. Endothelial cell interactions with granulocytes: tethering and signalling molecules. Immunol Today 1992;13:93-102.
55. Lawrence MB, Springer TA. Leucocytes roll on a selectin at physiological flow rates: distinction from and prerequisite for adhesion through integrins. Cell 1991;65:859-867.
56. Hammer DA, Apte SM. Simulation of cell rolling and adhesion on surfaces in shear flow: general results and analysis of selectin-mediated neutrophil adhesion. Biophys J 1992;63:35-43.
57. Larsen GR, Sako D, Ahern TJ, et al. P-selectin and E-selectin. Distinct but overlapping leucocyte ligand specificities. J Biol Chem 1992;267:11104-11112.
58. Smith CW, Marlin SD, Rothlein R, et al. Co-operative interactions of LFA-1 and Mac-1 with intercellular adhesion molecule-1 in facilitating adherence and transendothelial migration of human neutrophils in vitro. J Clin Invest 1989;83:2008-2017.
59. Albelda SM, Smith CW, Ward PA. Adhesion molecules and inflammatory injury. FASEB J 1994;8(8):504-512.
60. Harada A, Sekido N, Akahoshi T, et al. Essential involvement of interleukin-8 (IL-8) in acute inflammation. J Leukocyte Biol 1994;56(5):559-564.
61. Kishimoto TK, Jutila MA, Berg EL, et al. Neutrophil Mac-1 and MEL-14 adhesion proteins inversely regulated by chemotactic factors. Science 1989;245:1238-1245.
62. Huber R, Kunkel SL, Todd RF III, et al. Regulation of transendothelial neutrophil migration by endogenous interleukin-8. Science 1991;254:99-107.
63. Smolen JE, Boxer LA. Functions of neutrophils. In: Beutler E, Lichtman MA, Coller BS, et al. (eds). Williams Hematology, Fifth Edition. New York, NY, McGraw-Hill, 1995, pp 779-798.
64. Williams PL, Warwick R, Dyson M, et al. Gray's Anatomy, 38th Edition. London, UK, Churchill Livingstone, 1995.
65. Wahl SM. Acute and chronic inflammation. In: Zembala M, Asherson GL (eds). Human Monocytes. London, UK, Academic Press, 1989, pp 361-371.
66. Halliwell B. Oxidants and human disease: some new concepts. FASEB J 1987;1:358-365.
67. Simpson DM, Ross R. The neurophilic leukocyte in wound repair. A study with antineutrophil serum. J Clin Invest 1972;51:2009-2023.
68. Guirao X, Lowry SF. Biologic control of injury and inflammation: much more than too little or too late. World J Surg 1996;20(4):437-446.
69. Muller-Eberhard HJ. Complement: chemistry and pathways. In: Gallin JI, Goldstein IM, Synderman R (eds). Inflammation: Basic Principles and Clinical Correlates. New York, NY, Raven Press, 1992, pp 33-61.
70. Haslett C, Henson P. Resolution of inflammation. In: Clark RAF (ed). The Molecular and Cellular Biology of Wound Repair, Second Edition. London, UK, Plenum Press, 1996, pp 143-170.
71. Hosein B, Mosessen MW, Bianco C. Monocyte receptors for fibronectin. In: van Furth R (ed). Mononuclear Phagocytes: Characteristics, Physiology and Function. City?, Holland, Martuus Nijhoff, 1985.
72. Hunt TK. Prospective: a retrospective perspective on the nature of wounds. In: Barbul A, Pines E, Caldwell M, et al. (eds). Growth Factors and Other Aspects of Wound Healing. New York, NY, Liss, 1987.
73. Ho YS, Lee WMF, Synderman R. Chemoattractant induced activation of c-fos gene expression in human monocytes. J Exp Med 1987;165:1524-1538.
74. Newman SL, Henson JE, Henson PM. Phagocytosis of senescent neutrophils by human monocyte derived macrophages and rabbit inflammatory macrophages. J Exp Med 1982;156:430-442.
75. Tsukamoto Y, Helsel WE, Wahl SM. Macrophage production of fibronectin, a chemoattractant for fibroblasts. J Immunol 1981;127:673-678.
76. Campbell EJ, Cury JD, Lazarus CJ, et al. Monocyte procollagenase and tissue inhibitor of metalloproteinases. Identification, characterisation and regulation of secretion. J Biol Chem 1987;262:15862-15868.
77. Moulin V. Growth factors in skin wound healing. Eur J Cell Biol 1995;68(1):1-7.
78. Greenhalgh DG. The role of growth factors in wound healing. J Trauma 1996;41(1):159-167.
79. Shimokado K, Raines EW, Madles DK, et al. A significant part of macrophage derived growth factor consists of 2 forms of PDGF. Cell 1985;43:277-286.
80. Assoian RK, Fleurdelys BE, Stevenson HC, et al. Expression and secretion of type beta TGF, by activated human macrophages. Proc Natl Acad Sci USA 1987;84:6020-6024.
81. Madtes DK, Raines EW, Sakariassen KS, et al. Induction of transforming growth factor alpha in activated human alveolar macrophages. Cell 1988;53:285-293.
82. Baird A, Mormede P, Bohlen P. Immunoreactive fibroblast growth factor in cells of peritoneal exudate suggest its identity with macrophage growth factor. Biochem Biophys Res Commun 1985;126:358-364.
83. Eierman DF, Johnson CE, Haskill JS. Human monocyte inflammatory mediator gene expression is selectively regulated by adherence substrates. J Immunol 1989;142:1970-1976.
84. Leibovich SJ, Ross R. The role of macrophages in wound repair. A study of hydrocortisone and anti-macrophage serum. Am J Pathol 1975;78:71-100.
85. DiPietro LA. Wound healing: the role of the macrophage and other immune cells. Shock 1995;4(4):233-240.
86. Clark RAF. Basics of cutaneous wound repair. J Dermatol Surg Oncol 1993;19:693-706.
87. Kanzler MH, Gorsulowsky DC, Swanson NA. Basic mechanisms in the healing cutaneous wound. J Dermatol Surg Oncol 1986;12(11):1156-1164.
88. Hunt TK, van Winkle W. The fibroblast in normal repair. In: Hunt TK, Dunphy JE (eds). Fundamentals of Wound Management. New York, NY, Appleton-Centruy-Crofts, 1979.
89. Ciano PS, Colvin RB, Dvorak AM, et al. Macrophage migration in fibrin gel matrices. Lab Invest 1986;54:62-79.
90. Madri JA, Sankar S, Romanic AM. Angiogenesis. In: Clark RAF (ed). The Molecular and Cellular Biology of Wound Repair, Second Edition. London, UK, Plenum Press, 1996, pp 355-372.
91. McCarthy JB, Iida J, Furcht LT. Mechanisms of parenchymal cell migration into wounds. In: Clark RAF (ed). The Molecular and Cellular Biology of Wound Repair, Second Edition. London, UK, Plenum Press, 1996, pp 373-390.
92. Woodley DT. Reepithelialisation. In: Clark RAF (ed). The Molecular and Cellular Biology of Wound Repair, Second Edition. London, UK, Plenum Press, 1996, pp 339-354.
93. Winter GD. Formation of the scab and the rate of epithelialization of superficial wounds in the skin of the young domestic pig. Nature 1962;193:293-294.
94. Kirsner RS, Eaglstein WH. The wound healing process. Dermatologic Clinics 1993;11(4):629-640.
95. Gabbiani G, Chapponier C, Huttner I. Cytoplasmic filaments and gap junctions in epithelial cells and myofibroblasts, during wound healing. J Cell Biol 1978;76:561-568.
96. Odland G, Ross R. Human wound repair I. Epidermal regeneration. J Cell Biol 1968;39:135-151.
97. Waldorf H, Fewkes J. Wound healing. Advances in Dermatology 1995;10:77-96.
98. Winter GD. Epidermal regeneration studied in the domestic pig. In: Maibach HI, Rovee DT (eds). Epidermal Wound Healing. Chicago, IL, Year Book Medical Pub, 1972, pp 71-112.
99. Woodley DT, Chen JD, Kim JP, et al. Reepithelialization - human keratinocyte locomotion. Dermatologic Clinics 1993;11(4):641-646.
100. Dawson RA, Goberdhan NJ, Freedlander E, et al. Influence of extracellular matrix proteins on human keratinocyte attachment, proliferation and transfer to a dermal wound model. Burns 1996;22(2):93-100.
101. Kubo M, Norris DA, Howell SE, et al. Human keratinocytes synthesise, secrete and deposit fibronectin in the pericellular matrix. J Invest Dermatol 1984;82:580-586.
102. Clark RAF, Lanigan JM, Dellapelle P. Fibronectin and fibrin provide a provisional matrix for epidermal cell migration during wound reepithelialisation. J Invest Dermatol 1982;70:264-269.
103. Uitto J, Mauviel A, McGrath J. The dermal-epidermal basement membrane zone in cutaneous wound healing. In: Clark RAF (ed). The Molecular and Cellular Biology of Wound Repair, Second Edition. London, UK, Plenum Press, 1996, pp 513-560.
104. Grondahl-Hansen J, Lund LR, Ralfkiaer E, et al. Urokinase- and tissue-type plasminogen activators in keratinocytes during wound reepithelialisation in vivo. J Invest Dermatol 1980;90:790-795.
105. Wikner NE, Persichitte KA, Baskin JB, et al. Transforming growth factor beta stimulates the expression of fibronectin by human keratinocytes. J Invest Dermatol 1988;91:207-212.
106. Heinmark RL, Schwartz SM. The role of cell-cell interaction in the regulation of endothelial cell growth. In: Clark RAF, Henson PM (eds). The Molecular and Cellular Biology of Wound Repair. London, UK, Plenum Press, 1988, pp 359-371.
107. Hell E, Cruickshank CND. The effect of injury upon the uptake of H thymidine by guinea pig epidermis. Exp Cell Res 1963;31:128-139.
108. Christopher E. Kinetic aspects of epidermal healing. In: Maibach HI, Rovee DT (eds). Epidermal Wound Healing. Chicago, IL, Year Book Medical Pub, 1972, pp 53-70.
109. Werner S, Breeden M, Hubner G, et al. Induction of keratinocyte growth factor expression is reduced and delayed during wound heling in the genetically diabetic mouse. J Invest Dermatol 1994;103:469-475.
110. Bhora FY, Dunkin BJ, Batzri S, et al. Effect of growth factors on cell proliferation and epithelialisation in human skin. J Surg Res 1995;59(2):236-244.
111. Barrandon Y, Green H. Cell migration is essential for sustained growth of keratinocyte colonies: The roles of transforming growth factor alpha and epidermal growth factor. Cell 1987;50:1131-1137.
112. Werner S, Peters KG, Longaker MT, et al. Large induction of keratinocyte growth factor in the dermis during wound healing. Proc Natl Acad Sci USA 1992;89:6896-6900.
113. Higashiyama S, Abraham JA, Miller J, et al. A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF. Science 1991;251:936-939.
114. Meddahi A, Caruelle JP, Gold L, et al. New concepts in tissue repair: skin as an example. Diabetes and Metabolism 1996;22(4):274-278.
115. Antoniades HN, Galanopoulos T, Neville-Golden J, et al. Injury induces in vivo expression PDGF and PDGF receptor mRNAs in skin epithelial cells and PDGF mRNA in connective tissue fibroblasts. Proc Natl Acad Sci USA 1991;88:565-569.
116. Grossman RM, Krueger J, Yourish D, et al. Interleukin 6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes. Proc Natl Acad Sci USA 1989;86:6367-6371.
117. Krane JF, Murphy DP, Carter DM, et al. Synergistic effects of epidermal growth factor and insulin-like growth factor 1/somatemedin C on keratinocyte proliferation may be mediated by IGF 1 transmodulation of the EGF receptor. J Invest Dermatol 1991;96:419-124.
118. Coffrey RJ, Derynck R, Wilcox JN, et al. Induction and autoinduction of TGFα in human keratinocytes. Nature 1987;328:817-820.
119. Stephens P, Davies KJ, al-Khateeb T, et al. A comparison of the ability of intra-oral and extra-oral fibroblasts to stimulate extracellular matrix reorganisation in a model of wound contraction. J Dent Res 1996;75(6):1358-1364.
120. Welch MP, Odland GF, Clark RAF. Temporal relationships of F-actin bundle formation, collagen and fibronectin matrix assembly, and fibronectin receptor expression in wound contraction. J Cell Biol 1990;110:133-145.
121. Gabbiani G. The role of contractile proteins in wound healing, and fibrocontractive disease. Methods Achiev Exp Pathol 1979;9:187-206.
122. Majno G. The story of myofibroblasts. Am Surg Pathol 1979;3:535-542.
123. Desmouliere A, Gabbiani G. The role of the myofibroblast in wound healing and fibrocontractive diseases. In: Clark RAF (ed). The Molecular and Cellular Biology of Wound Repair, Second Edition. London, UK, Plenum Press, 1996, pp 391-426.
124. Horn DB. Growth factors in wound healing. Otolaryngologic Clinics of North America 1995;28(5):933-953.
125. Clark RAF. Mechanisms of cutaneous wound repair. In: Fitzpatrick TB, Eisen AZ, Wolff K, et al. (eds). Dermatology in General Medicine, Fourth Edition. New York, NY, McGraw-Hill, 1993, pp 473-186.
126. Senior RM, Griffin GL, Perez HD, et al. Human C5a and C5a des arg exhibit chemotactic activity for fibroblasts. J Immunol 1988;141:3570-3574.
127. Senior RM, Griffin GL, Huang JS, et al. Chemotactic activity of platelet alpha granule proteins for fibroblasts. J Cell Biol 1983;96:382-385.
128. Yang EY, Moses HL. Transforming growth factor-β1-induced changes in cell migration, proliferation and angiogenesis in the chicken chorioallantoic membrane. J Cell Biol 1990;111:731-741.
129. Tuan TL, Song A, Chang S, et al. In vitro fibroplasia: matrix contraction, cell growth, and collagen production of fibroblasts cultured in fibrin gels. Exp Cell Res 1996;223(1):127-134.
130. Postlethwaite AE, Seyer JM. Fibroblast chemotaxis induction by human recombinant interleukin-4: identification by synthetic peptide analysis of two chemotactic domains residing in amino acid sequences 70-88 and 89-122. J Clin Invest 1991;87:2147-2152.
131. Repesh LA, Fitzgerald TJ, Furcht LT. Fibronectin involvement in granulation tissue and wound healing in rabbits. J Histochem Cytochem 1982;30:351-358.
132. Lark MW, Laterra J, Culp LA. Close and focal contact adhesions of fibroblasts to a fibronectin-containing matrix. Fed Proc 1985;44:394-403.
133. Xu J, Clark RA. Extracellular matrix alters PDGF regulation of fibroblast integrins. J Cell Biol 1996; 132(1-2):239-249.
134. Saba TM, Jaffe E. Plasma fibronectin (opsonic glycoprotein): Its synthesis by vascular endothelial cells, and role in cardiopulmonary integrity after trauma, as related to reticuloendothelial function. Am J Med 1980;68:577-580.
135. Toole BP. Glycosaminoglycans in morphogenesis. In: Hay ED (ed) Cell Biology of Extracellular Martix. New York, NY, Plenum Press, 1981, pp 259-294.
136. Pledger WJ, Stiles CD, Antonides HN, et al. Induction of DNA synthesis in BALB/C 3T3 cells by serum components: reevaluation of the commitment process. Proc Natl Acad Sci USA 1977;74:4488-4490.
137. Scher CD, Shepard RC, Antoniades HN, et al. PDGF and the regulation of the mammalian fibroblast cell cycle. Biochem Biophys Acta 1979;560:217-219.
138. Grotendorst GR, Grotendorst CA, Gilman T. Production of growth factors (PDGF and TGFß) at the site of tissue repair. In: Barbul A, Pines E, Caldwell M, et al. (eds). Growth Factors and Other Aspects of Wound Healing: Biological and Clinical Implications. New York, NY, Liss Inc., 1988.
139. Kurkinen M, Vaheri A, Roberts PJ, et al. Sequential appearance of fibronectin and collagen in experimental granulation tissue. Lab Invest 1980;43:47-51.
140. Yamada K, Olden K. Fibronectins - adhesive glycoproteins of cell surface and blood. Nature 1978;275:179-184.
141. Granstein RD, Murphy GF, Margolis RJ, et al. Gamma interferon inhibits collagen synthesis in vivo in the mouse. J Clin Invest 1987;79:1254-1258.
142. Clark RAF, Nielsen LD, Welch MP, et al. Collagen matrices attenuate the collagen synthetic response of cultured fibroblasts to TGFß. J Cell Sci 1995;108:1251-1261.
143. Peacock EE. Contraction. In: Peacock EE (ed). Wound Repair, Third Edition. Philadelphia, PA, WB Saunders, 1984, 39-55.
144. Falanga V, Eaglstein WH. Wound healing, practical aspects. Prog Dermatol 1988;22:1-10.
145. Hunt TK, Heppenstall RB, Pines E, et al. Soft and Hard Tissue Repair. New York, NY, Praeger Scientific, 1984.
146. Gabbiani G, Ryan GB, Majno G. Presence of modified fibroblasts in granulation tissue, and their possible role in wound contraction. Experientia 1971;27:549-551.
147. Ehrlich HP, Rajaratnam JBM. Cell location forces versus cell contraction forces, for collagen lattice contraction. An in vitro model for wound contraction. Tissue and Cell 1990;22:407-411.
148. Singer II. The fibronexus; a transmembrane association of fibronectin-containing fibres and bundles of 5 run filaments in hamster and human fibroblasts. Cell 1979;16:675-685.
149. Schiro JA, Chan BMC, Roswit WR, et al. Integrin α2ß1 (VLA-2) mediates reorganisation and contraction of collagen matrices by human cells. Cell 1991;67:403-410.
150. Rudolph R. Contraction and the control of contraction. World J Surg 1980;4:279-287.
151. Stopak D, Harris AK. Connective tissue morphogenesis by fibroblasts traction I; tissue culture observations. Developmental Biology 1982;90:383-387.
152. Ehrlich HP. Wound closure: evidence of cooperation between fibroblasts and collagen matrix. Eye 1988;2:149-157.
153. Darby I, Skalli O, Gabbiani G. α-smooth muscle actin is transiently expressed by myofibroblasts during experimental wound healing. Lab Invest 1990;63:21-29.
154. Rappolee DA, Mark D, Banda MJ, et al. Wound macrophages express TGFα and other growth factors in vivo: Analysis by mRNA phenotyping. Science 1988;241:708-712.
155. Clark RAF, Folkvord JM, Hart CE, et al. Platelet isoforms of platelet-derived growth factor stimulate fibroblasts to contract collagen matrices. J Clin Invest 1989;84:1036-1040.
156. Alison MR. Repair and regenerative responses. In: McGee J, Isaacson PG, Wright NA, et al. (eds). Oxford Textbook of Pathology; Volume 1 Principles of Pathology. Oxford, UK, Oxford Uniersity Press, 1992, pp 365-388.
157. Findlay JK. Angiogenesis in reproductive tissues. J Endocr 1986;111:357-366.
158. Magnati P, Tsuboi R, Robbins E, et al. In vitro angiogenesis on the human amniotic membrane: requirement for bFGF-induced proteinases. J Cell Biol 1989;108:671-682.
159. Ausprunk DK, Boudreau CL, Nelson DA. Proteoglycans in the microvasculature II. Histochemical localization in proliferating capillaries of the rabbt cornea. Am J Pathol 1981;103:367-375.
160. Kalebic T, Garbisa S, Glaser B, et al. Basement membrane collagen: degradation by migrating endothelial cells. Science 1983;221:281-283.
161. Hashimoto H, Prewitt RL. Microvascular changes during wound healing. Int J Microdrc Clin Exp 1987;5:303-310.
162. Shepro D, Morel NM. Pericyte physiology. FASEB J 1993;7(11):1031-1038.
163. Kitchen S, Young SR. Tissue repair. In: Kitchen S, Bazin S (eds). Clayton's Electrotherapy 10E. London, UK, W.B. Saunders, 1996 pp 47-60.
164. Desmouliere A, Redard M, Darby I, et al. Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar. Am J Path 1995;146(1):56-66.
165. Folkman J. Angiogenesis: initiation and control. Ann NY Acad Sci 1982;401:212-227.
166. Folkman J, Shing T. Angiogenesis. J Biol Chem 1992;267:10931-10934.
167. Koch AE, Polverini PJ, Kunkel SL, et al. Interleukin 8 as a macrophage-derived mediator of angiogenesis. Science 1992;258:1798-1801.
168. Imre G. Studies on the mechanism of retinal neovascularization. Role of lactic acid. Br J Ophthalmol 1964;48:75-82.
169. Zauberman H, Michaelson IC, Bergmann F, et al. Stimulation of neovascularization of the cornea by biogenie amines. Exp Eye Res 1969;8:77-83.
170. Knighton DR, Hunt TK, Schevenstuhl, et al. Oxygen tension regulates the expression of angiogenesis factor by macrophages. Science 1983;221:1283-1285.
171. Ishikawa F, Miyazono K, Hellman U, et al. Identification of angiogenic activity and the cloning and expression of PD-ECGF. Nature 1989;338:557-562.
172. Weisman DM, Polverini PJ, Kamp DW. Transforming growth factor beta is chemotactic for human monocytes and induces their expression of angiogenic activity. Biochem Biophys Res Commun 1988;157:793-800.
173. Battegay EF, Rupp J, Iruela-Arispe L, et al. PDGF-BB modulates endothelial proliferation and angiogenesis in vitro via PDGF ß receptors. J Cell Biol 1994;125:917-928.
174. Azizkhan RG, Azizkhan JC, Zetter BR, et al. Mast cell heparin stimulates migration of capillary endothelial cells in vitro. J Exp Med 1980;152:931-944.
175. Birdwell CR, Gospodarowicz D, Nicholson GL. Identification, localisation and the role of fibronectin in cultured bovine endothelial cells. Proc Natl Acad Sci USA 1978;75:3273-3277.
176. Madri JA, Stenn KS. Aortic endothelial cell migration I. Matrix requirements and composition. Am J Path 1982;106:180-186.
177. Orlidge A, D'Amore PA. Inhibition of capillary endothelial cell growth by pericytes and smooth muscle cells. J Cell Biol 1987;105:1455-1462.
178. Richter C, Schweizer M, Cossarizza A, et al. Control of apoptosis by the cellular ATP level. FEBS Letters 1996;378(2):107-110.
179. Wilson SE, He YG, Weng J, et al. Epithelial injury induces keratocyte apoptosis: hypothesised role for the interleukin-1 system in the modulation of corneal tissue organisation and wound healing. Exp Eye Res 1996;62(4):325-327.
180. Hale AJ, Smith CA, Sutherland LC, et al. Apoptosis: molecular regulation of cell death. Eur J Biochem 1996;236(1):1-26.
181. Boldin MP, Goncharov TM, Goltsev YV, et al. Involvement of MACH, a novel MORTl/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death. Cell 1996;85:803-815.
182. Hopkinson-Woolley J, Hughes D, Gordon S, et al. Macrophage recruitment during limb development and wound healing in the embryonic and foetal mouse. J Cell Sci 1994;107(5):1159-1167.
183. Chvapil M, Koopman CF. Scar formation: physiology and pathological states. Otolaryngol Clin N Am 1984;17:265-272.
184. Levenson SM, Geever EF, Crowley LV, et al. The healing of rat skin wounds. Ann Surg 1965;161:293-308.
185. Pickett BP, Burgess LP, Livermore GH, et al. Wound healing. Tensile strength vs. healing time for wounds closed under tension. Archives of Otolaryngology - Head and Nech Surgery 1996;122(5):565-568.
186. Compton CC, Gill JM, Bradford DA, et al. Skin regenerated from cultured epithelial autographs on full-thickness burn wounds from 6 days to 5 years after grafting. A light electron microscope and immunohistochemical study. Lab Invest 1989;60:600-612.
187. Bailey AJ, Bazin S, Sims TJ, et al. Characterization of the collagen of human hypertrophic and normal scars. Biochem Biophys Acta 1975;405:412-421.
188. Laato M, Kahari VM, Niniikoski J, et al. Epidermal growth factor increases collagen production in granulation tissue by stimulation of fibroblast proliferation and not by activation of procollagen genes. Biochem 1987;247:385-388.
189. Kimura Y, Torimura T, Ueno T, et al. Transforming growth factor beta 1, extracellular matrix, and inflammatory cells in wound repair using a closed duodenal loop pancreatitis model rat. Immunohistochemical Study 1995;30(7):707-714.
190. Hynes R. Molecular biology of fibronectin. Annu Rev Cell Biol 1985;1:67-71.
191. Yamada KM. Fibronectin and other cell interactive glycoproteins. In: Hay ED (ed). Cell Biology of Extracellular Matrix, Second Edition. New York, NY, Plenum Press, 1991, pp 111-139.
192. Brown LF, Dubin D, Lavinge L, et al. Macrophages and fibroblasts express "embryonic" fibronectins during cutaneous wound healing. Am J Pathol 1993;142:793-801.
193. Corbett SA, Wilson CL, Schwarzbauer JE. Changes in cell spreading and cytoskeletal organisation are induced by adhesion to a fibronectin-fibrin matrix. Blood 1996;88(1):158-166.
194. Grinnell F, Feld M, Minter D. Fibroblast adhesion to fibrinogen and fibrin substrata: requirement for cold-insolule globulin (plasma fibronectin). Cell 1980;19:517-525.
195. Brown EJ, Goodwin JL. Fibronectin receptors of phagocytes. Characterisation of the arg-gly-asp binding proteins of human monocytes and polymorphonuclear leucocytes. J Exp Med 1988;167:777-793.
196. Clark RAF. Potential roles of fibronectin in cutaneous wound repair. Arch Dermatol 1988;124:201-206.
197. Vartio T, Seppa H, Vaheri A. Susceptibility of soluble and matrix fibronectins to degradation by tissue proteases, mast cell chymase and cathepepsin. J Biol Chem 1981;256:471-177.
198. Alvarez OM, Goslen JB, Eaglstein WH, et al. Wound healing. In: Fitzpatrick TB, Eisen AZ, Wolff K, et al. (eds). Dermatology in General Medicine, Third Edition. New York, NY, McGraw-Hill, 1987, pp 321-336.
199. Sampson PM, Rochester CL, Freundlich B, et al. Cytokine regulation of human lung fibroblast hyaluronan (hyaluronic acid) production: evidence for cytokine-regulated hyaluronan (hyaluronic acid) degradation and human lung fibroblast-derived hyaluronidase. J Clin Invest 1992;90:1492-1503.
200. Balazs A, Holmgren HJ. The basic dye-uptake and the presence of growth inhibiting substance in the healing tissue of skin wounds. Exp Cell Res 1950;1:206-216.
201. Bentley JP. Rate of chondroitin sulphate formation in wound healing. Ann Surg 1967;165:186-191.
202. Toole BP. Hyaluronate turnover during chondrogenesis in the developing chick limb and axial skeleton. Dev Biol 1972;29:321-329.
203. Gallo RL, Bernfield M. Proteoglycans and their role in wound repair. In: Clark RAF (ed). The Molecular and Cellular Biology of Wound Repair, Second Edition. London, UK, Plenum Press, 1996, pp 475-492.
204. Culp LA, Murray BA, Rollins BJ. Fibronectin and proteoglycans as determinants of cell-substratum adhesion. J Supramol Struct 1979;11:401-427.
205. Underhill C. CD44: the hyaluronan receptor. J Cell Sci 1992;103:293-298.
206. Turley EA. Hyaluronan and cell locomotion. Cancer Metastasis Rev 1992;11:21-30.
207. Stamenkovic I, Aruffo A. Hyaluronic acid receptors. In: Ruoslahti E, Engvall E (eds). Methods in Enzymology. San Diego, CA, Academic Press, 1994, pp 195-218.
208. Yang B. Yang B, Savani RC, et al. Identification of a common hyaluronan binding motif in the hyaluronan binding proteins RHAMM, CD44 and link protein. EMBO J 1994;13:286-296.
209. Thomas L, Byers HR, Vink J, et al. CD44H regulates tumour cell migration on hyaluronate-coated substrate. J Cell Biol 1992;118:971-977.
210. Hopwood JJ, Dorfman A. Glycosaminoglycan synthesis by cultured human skin fibroblasts after transformation with simian virus 40. J Bio Chem 1977;252:4777-4785.
211. Tomida M, Koyama H, Ono T. Induction of hyaluronic acid synthetase activity in rat fibroblasts by medium change of confluent cultures. J Cell Physiol 1975;86:121-130.
212. Moscatelli D, Rubin H. Increased hyaluronic acid production on stimulation of DNA synthesis in chick embryo fibroblasts. Nature 1975;254:65-66.
213. Lembach KJ. Enhanced synthesis and extracellular accumulation of hyaluronic acid during stimulation of quiescent human fibroblasts by mouse epidermal growth factor. J Cell Physiol 1976;89:277-288.
214. Alho AM, Underhill CM. The hyaluronate receptor is preferentially expressed on proliferating epithelial cells. J Cell Biol 1989;108:1557-1566.
215. Ruggiero SL, Bertolami CN, Bronson RE, et al. Hyaluronidase activity of rabbit skin wound granulation tissue fibroblasts. J Dent Res 1987;66:1283-1287.
216. Hascall VC, Hascall GK. Proteoglycans. In: Hay EB (ed). Cell Biology of Extracellular Matrix. New York, NY, Plenum Press, 1981, pp 39-63.
217. Bronson RE, Argenta JG, Bertolami N. Interleukin 1 induced changes in extracellular glycosaminoglycan composition of cutaneous scar-derived fibroblasts in culture. Coll Rel Res 1988;8:199-208.
218. Wight TN, Heinegard DK, Hascall HV. Proteoglycans: structure and function. In: Hay EB (ed). Cell Biology of Extracellular Matrix. New York, NY, Plenum Press, 1991, pp 45-78.
219. Raines EW, Ross R. Platelet-derived growth factor: high yield purification and evidence for multiple forms. J Biol Chem 1985;257:5154-5157.
220. Scott JE. Proteoglycan-fibrillar collagen interactions in tissues: dermatan sulphate proteoglycan as a tissue organiser. Dermatan Sulphate Proteoglycans: Chemistry, Biology, Chemical Pathology. London, UK, Portland Press, 1993, pp 165-181.
221. Ross RR, Raines EW. Platelet-derived growth factor and cell proliferation. In: Sara VR (ed). Growth Factors: From Genes to Clinical Application. New York, NY, Raven Press, 1990, pp 193-199.
222. Perin JP, Bonnet F, Mailet P, et al. Characterisation and N-terminal sequence of human platelet proteoglycan. Biochem J 1988;255:1007-1013.
223. Kischer CW, Shetlar MR. Collagen and mucopolysaccharides in the hypertrophic scar. Connect Tissue Res 1974;2:205-213.
224. Shetlar MR, Shetlar CL, Chien SF, et al. The hypertrophic scar. Hexosamine containing components of burn scars. Proc Soc Exp Biol Med 1972;139:544-547.
225. Underhill CB, Keller JM. Density dependent changes in the amount of sulphated glycosaminoglycans associated with mouse 3T3 cells. J Cell Physiol 1976;89:53-63.
226. Kraemer PM, Tobey RA. Cell-cycle-dependent desquamation of heparan sulphate from the cell surface. J Cell Biol 1972;55:713-717.
227. Fukai N, Apte SS, Olsen BR. Non-fibrillar collagens. In: Ruoslahti E, Engvall E (eds). Extracellular Matrix Components. San Diego, CA, Academic Press, 1994, pp 3-28.
228. Birk DE, Zycband EI, Winkleman DA. Collagen fibrillogenesis in situ. NY Acad Sci 1990;580:176-194.
229. Hopkinson I. The extracellular matrix in wound healing: collagen in wound healing. WOUNDS 1992;4(4):124-132.
230. Alvarez OM. The effect of occlusive dressings on collagen synthesis and reepithelialisation in superficial wounds. J Surg Res 1983;35:142-145.
231. Gay S, Viljanto J, Raekallio J, et al. Collagen types in early phases of wound healing in children. Acta Chir Scand 1978;144:205-207.
232. Clone JN, Cohen IK, Diegelmann RF. Quantitation of the collagen types I and III during wound healing in the rat skin. Proc Soc Exp Biol Med 1979;161:337-340.
233. Hering TM, Marchant RE, Anderson JM. Type V collagen during granulation tissue development. Exp Mol Pathol 1983;39:219-229.
234. Ehrlich HP, White BS. The identification of A and B collagen chains in hypertrophic scars. Exp Mol Pathol 1981;34:1-8.
235. Oono T, Specks U, Eckes B. Expression of type VI collagen mRNA during wound healing. J Invest Dermatol 1993;100:329-334.
236. Keene DR, Engvall E, Glanvill RW. Ultrastructure of type VI collagen in human skin and cartilage suggests an anchoring function for this filamentous work. J Cell Biol 1988;107:1995-2006.
237. Eckes B, Aumailley M, Krieg T. Collagens and the reestablishment of dermal integrity. In: Clark RAF (ed). The Molecular and Cellular Biology of Wound Repair 560, Second Edition. London, UK, Plenum Press, 1996, pp 530-560.
238. Cotran RS, Kumar V, Robbins SL, et al. Robbins Pathologic Basis of Disease, Fifth Edition. Philadelphia, PA, WB Saunders Company, 1994.
239. Trelstad RL, Silver FH. Matrix assembly. In: Hay EB (ed). Cell Biology of Extracellular Matrix. New York, NY, Plenum Press, 1981, pp 179-194.
240. Postlethwaite AE, Seyer JM, Kang AH. Chemotactic attraction of human fibroblast to type I, II and III collagens and collagen derived peptides. Proc Natl Acad Sci USA 1978;75:871-875.
241. Grinnell F. Fibroblasts, myofibroblasts and wound contraction. J Cell Biol 1994;124:401-404.
242. Unemore EN, Werb Z. Reorganisation of polymerized actin: a possible trigger for induction of procollagenase in fibroblasts in and on collagen gels. J Cell Biol 1986;103:1021-1031.
243. Klein CE, Dressel D, Steinmayer T, et al. Integrin α2ß1 is up-regulated in fibroblasts and highly aggressive melanoma cells in three dimensional collagen lattices and mediates the re-organisation of collagen I fibrils. J Cell Biol 1991;115:1427-1436.
244. Stricklin GP, Li L, Jancic V, et al. Localisation of mRNAs representing collagenase and TIMP in sections of healing human burn wounds. Am J Pathol 1993;143:1657-1666.
245. Mignatti P, Rifkin DB, Welgus HG, et al. In: Clark RAF (ed). The Molecular and Cellular Biology of Wound Repair, Second Edition. London, UK, Plenum Press, 1996, pp 427-474.
246. Grant GA, Eisen AZ, Marmer BL, et al. The activation of human skin fibroblast procollagenase. Sequence identification of the major conversion products. J Biol Chem 1987;262:5886-5889.
247. Hibbs MS, Hoidal JR, Kang AH. Expression of metalloproteinase that degrades native type V collagen and denatured collagens by cultured human alveolar macrophages. J Clin Invest 1987;80:1644-1650.
248. Stetler-Stevenson WG, Krutzsch HC, Wacher MP, et al. The activation of human type IV collagenase proenzyme. Sequence identification of the major conversion product following organomercurial activation. J Biol Chem 1989;264:1353-1356.
249. Saus J, Quinones S, Otani Y, et al. The complete primary structure of human matrix metalloproteinase 3. Identity with stromelysin. J Biol Chem 1988;263:6742-6745.
250. Sporn MB, Roberts AB, Wakefield L, et al. Some recent advances in the chemistry and biology of transforming growth factor beta. J Cell Biol 1987;105:1039-1045.
251. Shah M, Foreman DM, Ferguson MW. Neutralisation of TGF-beta 1 and TGF-beta 2 or exogenous addition of TGF-beta 3 to cutaneous rat wounds reduces scarring. J Cell Sci 1995;108(3):985-1002.
252. Brenner CA, Adler RR, Rappolee DA, et al. Genes for extracellular matrix-degrading metalloproteases and their inhibitor TIMP are expressed during early mammalian development. Genes Dev 1989;3:848-859.